| 3β-hydroxysteroid dehydrogenase/Δ-5-4 isomerase | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| EC number | 1.1.1.145 | ||||||
| CAS number | 9044-85-3 | ||||||
| Databases | |||||||
| IntEnz | IntEnz view | ||||||
| BRENDA | BRENDA entry | ||||||
| ExPASy | NiceZyme view | ||||||
| KEGG | KEGG entry | ||||||
| MetaCyc | metabolic pathway | ||||||
| PRIAM | profile | ||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||
| Gene Ontology | AmiGO / EGO | ||||||
|
|||||||
| hydroxy-Δ-5-steroid dehydrogenase, 3β- and steroid Δ-isomerase 1 |
|
|---|---|
| Identifiers | |
| Symbol | HSD3B1 |
| Alt. symbols | HSDB3, HSD3B |
| Entrez | 3283 |
| HUGO | 5217 |
| OMIM | 109715 |
| RefSeq | NM_000862 |
| UniProt | P14060 |
| Other data | |
| EC number | 1.1.1.145 |
| Locus | Chr. 1 p13-p11 |
| hydroxy-Δ-5-steroid dehydrogenase, 3β- and steroid Δ-isomerase 2 |
|
|---|---|
| Identifiers | |
| Symbol | HSD3B2 |
| Entrez | 3284 |
| HUGO | 5218 |
| OMIM | 613890 |
| RefSeq | NM_000198 |
| UniProt | P26439 |
| Other data | |
| EC number | 1.1.1.145 |
| Locus | Chr. 1 p13.1 |
3-β-HSD (or 3-β-hydroxysteroid dehydrogenase/Δ-5-4 isomerase) is an enzyme that catalyses the synthesis of progesterone from pregnenolone, 17-hydroxyprogesterone from 17-hydroxypregnenolone, and androstenedione from dehydroepiandrosterone in the adrenal gland. It is the only enzyme in the adrenal pathway of corticosteroid synthesis that is not a member of the Cytochrome P450 family.[1] In humans, there are two 3-β-HSD isozymes encoded by the HSD3B1 and HSD3B2 genes, respectively.
It is also known as delta 5-delta 4-isomerase, which catalyzes the oxidative conversion of delta 5-3 beta- hydroxysteroids to the delta 4-3-keto configuration and is, therefore, essential for the biosynthesis of all classes of hormonal steroids, namely progesterone, glucocorticoids, mineralocorticoids, androgens, and estrogens.[2] The 3-beta HSD complex is responsible for the conversion of:
|
Contents
|
3-β-HSD belongs to the family of oxidoreductases, to be specific, those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. This enzyme participates in c21-steroid hormone metabolism and androgen and estrogen metabolism.
3-β-HSD catalyzes the chemical reaction:
a 3-oxo-Δ5-steroid + NADH + H+Thus, the two substrates of this enzyme are 3β-hydroxy-Δ5-steroid and NAD+, whereas its 3 products are 3-oxo-Δ5-steroid, NADH, and H+.
Humans express two 3-β-HSD isozymes, HSD3B1 (type I) and HSD3B2 (type II).[3] The type I isoenzyme is expressed in placenta and peripheral tissues, whereas the type II 3β-HSD isoenzyme is expressed in the adrenal gland, ovary, and testis.
The systematic name of this enzyme class is 3β-hydroxy-Δ5-steroid:NAD+ 3-oxidoreductase. Other names in common use include:
3-β-HSD is inhibited by trilostane.[4]
|
A deficiency in the type II form through mutations in HSD3B2 is responsible for a rare form of congenital adrenal hyperplasia.[5] No human condition has yet been linked to a deficiency in the type I enzyme. Its importance in placental progesterone production expression suggests that such a mutation would be embryonically lethal.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This EC 1.1.1 enzyme-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)